Trial · NCT03595618
Results by group134
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 134
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Cartilage Thickness of the cMTFC as Assessed by qMRI on the Target Knee to Week 52 | GLPG1972 75 mg | -0.06791 | Standard Deviation 0.20169 | mm | |
| Change From Baseline in Cartilage Thickness of the cMTFC as Assessed by qMRI on the Target Knee to Week 52 | GLPG1972 150 mg | -0.09693 | Standard Deviation 0.26839 | mm | |
| Change From Baseline in Cartilage Thickness of the cMTFC as Assessed by qMRI on the Target Knee to Week 52 | GLPG1972 300 mg | -0.08545 | Standard Deviation 0.21697 | mm | |
| Change From Baseline in Cartilage Thickness of the cMTFC as Assessed by qMRI on the Target Knee to Week 52 | Placebo | -0.11562 | Standard Deviation 0.27275 | mm | |
| Number of Participants Who Were Osteoarthritis (OA) Structural Progressors Based on Cartilage Thickness in the cMTFC Assessed by qMRI on the Target Knee | GLPG1972 75 mg | 22 | Participants | ||
| Number of Participants Who Were Osteoarthritis (OA) Structural Progressors Based on Cartilage Thickness in the cMTFC Assessed by qMRI on the Target Knee | GLPG1972 150 mg | 34 | Participants | ||
| Number of Participants Who Were Osteoarthritis (OA) Structural Progressors Based on Cartilage Thickness in the cMTFC Assessed by qMRI on the Target Knee | GLPG1972 300 mg | 25 | Participants | ||
| Number of Participants Who Were Osteoarthritis (OA) Structural Progressors Based on Cartilage Thickness in the cMTFC Assessed by qMRI on the Target Knee | Placebo | 35 | Participants | ||
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | GLPG1972 75 mg | Total score: Baseline | 48.0 | Standard Deviation 15.2 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | GLPG1972 150 mg | Total score: Baseline | 48.7 | Standard Deviation 15.0 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | GLPG1972 300 mg | Total score: Baseline | 47.0 | Standard Deviation 15.2 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | Placebo | Total score: Baseline | 48.3 | Standard Deviation 14.5 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | GLPG1972 75 mg | Total score: Change from baseline to Week 52 | -16.3 | Standard Deviation 17.7 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | GLPG1972 150 mg | Total score: Change from baseline to Week 52 | -16.9 | Standard Deviation 17.7 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | GLPG1972 300 mg | Total score: Change from baseline to Week 52 | -16.1 | Standard Deviation 19.8 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | Placebo | Total score: Change from baseline to Week 52 | -18.4 | Standard Deviation 18.9 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | GLPG1972 75 mg | Pain subscore: Baseline | 10.2 | Standard Deviation 3.2 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | GLPG1972 150 mg | Pain subscore: Baseline | 10.0 | Standard Deviation 3.1 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | GLPG1972 300 mg | Pain subscore: Baseline | 9.8 | Standard Deviation 3.1 | score on a scale |
| Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score and Subscales Scores for Pain, Function, and Stiffness to Week 52 | Placebo | Pain subscore: Baseline | 10.0 | Standard Deviation 3.2 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03595618/results